HOWL - Werewolf Therapeutics jumps ~10% after RA Capital ups stake says may engage in talks

• Healthcare and life sciences focused investment management firm RA Capital along with its managing partners Peter Kolchinsky and Rajeev Shah have raised their active stake in cancer-focused biopharma Werewolf Therapeutics ( NASDAQ: HOWL ).
• RA Capital Management, Peter Kolchinsky and Rajeev Shah (the reporting persons) increased their stake to 17.96% from 14.57% previously, a filing with the U.S. Securities and Exchange Commission (SEC) on Tuesday showed.
• The filing also said the reporting persons could engage in talks with HOWL to discuss strategic alternatives such as potential business combinations.
• Shares of HOWL jumped 10.3% to $2.46 after hours.
• RA Capital invests in several biotech and healthcare firms with around 100 companies in its portfolio.

For further details see: